Orchard Therapeutics
(NASDAQ:ORTX)
$0.57
-0.0142[-2.43%]
At close: Jul 1
$0.59
0.0200[3.51%]
After Hours: 7:36PM EDT
Day High/Low0.56 - 0.62
52 Week High/Low0.41 - 4.63
Open / Close0.57 / 0.57
Float / Outstanding- / 125.9M
Vol / Avg.1.4M / 738.7K
Mkt Cap71.8M
P/E-
50d Avg. Price0.52
Div / Yield-
Payout Ratio-
EPS-0.35
Total Float117.3M

Orchard Therapeutics (NASDAQ:ORTX), Quotes and News Summary

Orchard Therapeutics (NASDAQ: ORTX)

Day High/Low0.56 - 0.62
52 Week High/Low0.41 - 4.63
Open / Close0.57 / 0.57
Float / Outstanding- / 125.9M
Vol / Avg.1.4M / 738.7K
Mkt Cap71.8M
P/E-
50d Avg. Price0.52
Div / Yield-
Payout Ratio-
EPS-0.35
Total Float117.3M
load more
Sector: Health Care.Industry: Biotechnology
Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-0.260-0.350 -0.0900
REV3.960M5.524M1.564M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Orchard Therapeutics Questions & Answers

Q
How do I buy Orchard Therapeutics (ORTX) stock?
A

You can purchase shares of Orchard Therapeutics (NASDAQ: ORTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Orchard Therapeutics's (ORTX) competitors?
Q
What is the target price for Orchard Therapeutics (ORTX) stock?
A

The latest price target for Orchard Therapeutics (NASDAQ: ORTX) was reported by Barclays on Friday, May 13, 2022. The analyst firm set a price target for 4.00 expecting ORTX to rise to within 12 months (a possible 601.75% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Orchard Therapeutics (ORTX)?
A

The stock price for Orchard Therapeutics (NASDAQ: ORTX) is $0.57 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Orchard Therapeutics (ORTX) pay a dividend?
A

There are no upcoming dividends for Orchard Therapeutics.

Q
When is Orchard Therapeutics (NASDAQ:ORTX) reporting earnings?
A

Orchard Therapeutics’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is Orchard Therapeutics (ORTX) going to split?
A

There is no upcoming split for Orchard Therapeutics.

Q
What sector and industry does Orchard Therapeutics (ORTX) operate in?
A

Orchard Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.